Stelara

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2008-2016
0120082016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Newly released data from the first drug to exclusively inhibit the pro-inflammatory cytokine interleukin-23 (IL-23) show similar… (More)
  • table 1
Is this relevant?
2014
2014
it tried to show that Janssen’s Stelara (ustekinumab) — an antibody binding to interleukin‐12 (IL‐12) and IL‐23 that is marketed… (More)
Is this relevant?
2009
2009
  • 2009
594 P&T® • November 2009 • Vol. 34 No. 11 NEW DRUGS Stelara for Psoriasis Ustekinumab (Stelara, Centocor Ortho Biotech Inc.), a… (More)
Is this relevant?
Review
2008
Review
2008
Later this month, the US Food and Drug Administration (FDA) will decide whether a new psoriasis drug, Stelara (ustekinumab), can… (More)
  • figure 1
Is this relevant?